Benzinga | Jan 26, 2022 04:24PM EST

Recap: Vertex Pharmaceuticals Q4 Earnings

Vertex Pharmaceuticals (NASDAQ:VRTX) reported its Q4 earnings results on Wednesday, January 26, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Vertex Pharmaceuticals beat estimated earnings by 2.43%, reporting an EPS of $3.37 versus an estimate of $3.29, which did not surprise analysts.

Revenue was up $445.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.48, which was followed by a 4.23% increase in the share price the next day.

Here's a look at Vertex Pharmaceuticals's past performance:



Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020EPS Estimate 3.08 2.28 2.69 2.59EPS Actual 3.56 3.11 2.98 2.51Revenue Estimate 1.86B 1.72B 1.66B 1.58BRevenue Actual 1.98B 1.79B 1.72B 1.63B

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.